The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0/G1 arrest and apoptosisZhanzhan Feng, Luoting Yu, Yufei Yang et al.|Cell Death and Disease|2018Cited by 87
YLT-11, a novel PLK4 inhibitor, inhibits human breast cancer growth via inducing maladjusted centriole duplication and mitotic defectQian Lei, Luoting Yu, Tinghong Ye et al.|Cell Death and Disease|2018Cited by 65
Repositioning antipsychotic fluphenazine hydrochloride for treating triple negative breast cancer with brain metastases and lung metastases.Fuyan Xu, Luoting Yu, Jinrui Jiang et al.|PubMed|2019Cited by 45
Novel selective TOPK inhibitor SKLB-C05 inhibits colorectal carcinoma growth and metastasisTiantao Gao, Luoting Yu, Weiqiong Zuo et al.|Cancer Letters|2018Cited by 43
Design and Synthesis of Fibroblast Growth Factor Receptor (FGFR) and Histone Deacetylase (HDAC) Dual Inhibitors for the Treatment of CancerGuoquan Wan, Luoting Yu, Chang Su et al.|Journal of Medicinal Chemistry|2022Cited by 28